Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. DEF 14A Proxy Proxy Statement
  2. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  3. 4 Open-market buy Director bought 5,800 shares at $45.51 ($263,970)
  4. 4 Grant or award Chief Financial Officer acquired 10,303 shares (grant or award)
  5. 4 Open-market buy CEO bought 25,000 shares at $46.27 ($1,156,800)
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. S-3ASR Offering Registration Statement
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations
  10. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  11. 8-K/A Event Executive or director change
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Open-market sale CEO sold 1,262 shares at $66.65 ($84,112)
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 8-K Event Executive or director change
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Material agreement · Other events
  20. 424B5 Offering Prospectus

Page 18 of 37 · 731 filings